S05.1 Efficacy and safety of the anti-SARS-CoV-2 BNT162b2 vaccine among SLE patients: the covalus project

Bibliographic Details
Main Authors: V Ferré, T Papo, N Charles, A Mageau, P Nicaise Roland, T Goulenok, J Tchen, K Sacre
Format: Article
Language:English
Published: BMJ Publishing Group 2022-10-01
Series:Lupus Science and Medicine
_version_ 1811342158250115072
author V Ferré
T Papo
N Charles
A Mageau
P Nicaise Roland
T Goulenok
J Tchen
K Sacre
author_facet V Ferré
T Papo
N Charles
A Mageau
P Nicaise Roland
T Goulenok
J Tchen
K Sacre
author_sort V Ferré
collection DOAJ
first_indexed 2024-04-13T19:06:35Z
format Article
id doaj.art-051d90c06d984dc3b1bf00e63f86eab9
institution Directory Open Access Journal
issn 2053-8790
language English
last_indexed 2024-04-13T19:06:35Z
publishDate 2022-10-01
publisher BMJ Publishing Group
record_format Article
series Lupus Science and Medicine
spelling doaj.art-051d90c06d984dc3b1bf00e63f86eab92022-12-22T02:33:57ZengBMJ Publishing GroupLupus Science and Medicine2053-87902022-10-019Suppl 210.1136/lupus-2022-elm2022.11S05.1 Efficacy and safety of the anti-SARS-CoV-2 BNT162b2 vaccine among SLE patients: the covalus projectV Ferré0T Papo1N Charles2A Mageau3P Nicaise Roland4T Goulenok5J Tchen6K Sacre72Inserm UMR 1137 IAME, service de virologie, hôpital Bichat, AP-HP ~ Paris ~ FranceDepartment of Internal Medicine, Hôpital Bichat-Claude Bernard, Paris6Université de Paris, Centre de Recherche sur l’Inflammation, INSERM UMR1149, CNRS ERL8252, Faculté de Médecine site Bichat, Laboratoire d’Excellence Inflamex ~ Paris ~ France1Inserm UMR 1137 IAME and1149 CRI, service de médecine interne, hôpital Bichat, AP-HP ~ Paris ~ France3Service d’immunologie, hôpital Bichat, AP-HP ~ Paris ~ France5Service de médecine interne, hôpital Bichat, AP-HP ~ Paris ~ France6Université de Paris, Centre de Recherche sur l’Inflammation, INSERM UMR1149, CNRS ERL8252, Faculté de Médecine site Bichat, Laboratoire d’Excellence Inflamex ~ Paris ~ France4Inserm UMR1149 CRI, Service de médecine interne, hôpital Bichat ~ Paris ~ France
spellingShingle V Ferré
T Papo
N Charles
A Mageau
P Nicaise Roland
T Goulenok
J Tchen
K Sacre
S05.1 Efficacy and safety of the anti-SARS-CoV-2 BNT162b2 vaccine among SLE patients: the covalus project
Lupus Science and Medicine
title S05.1 Efficacy and safety of the anti-SARS-CoV-2 BNT162b2 vaccine among SLE patients: the covalus project
title_full S05.1 Efficacy and safety of the anti-SARS-CoV-2 BNT162b2 vaccine among SLE patients: the covalus project
title_fullStr S05.1 Efficacy and safety of the anti-SARS-CoV-2 BNT162b2 vaccine among SLE patients: the covalus project
title_full_unstemmed S05.1 Efficacy and safety of the anti-SARS-CoV-2 BNT162b2 vaccine among SLE patients: the covalus project
title_short S05.1 Efficacy and safety of the anti-SARS-CoV-2 BNT162b2 vaccine among SLE patients: the covalus project
title_sort s05 1 efficacy and safety of the anti sars cov 2 bnt162b2 vaccine among sle patients the covalus project
work_keys_str_mv AT vferre s051efficacyandsafetyoftheantisarscov2bnt162b2vaccineamongslepatientsthecovalusproject
AT tpapo s051efficacyandsafetyoftheantisarscov2bnt162b2vaccineamongslepatientsthecovalusproject
AT ncharles s051efficacyandsafetyoftheantisarscov2bnt162b2vaccineamongslepatientsthecovalusproject
AT amageau s051efficacyandsafetyoftheantisarscov2bnt162b2vaccineamongslepatientsthecovalusproject
AT pnicaiseroland s051efficacyandsafetyoftheantisarscov2bnt162b2vaccineamongslepatientsthecovalusproject
AT tgoulenok s051efficacyandsafetyoftheantisarscov2bnt162b2vaccineamongslepatientsthecovalusproject
AT jtchen s051efficacyandsafetyoftheantisarscov2bnt162b2vaccineamongslepatientsthecovalusproject
AT ksacre s051efficacyandsafetyoftheantisarscov2bnt162b2vaccineamongslepatientsthecovalusproject